Forget FAANGs - look to the US for the world's best biotech

New drug launches need private finance

clock • 4 min read
Marek Poszepczynski and Ailsa Craig of the International Biotechnology Trust
Image:

Marek Poszepczynski and Ailsa Craig of the International Biotechnology Trust

The development of not one but several Covid-19 vaccines in a mere matter of months has captured the imagination of investors. With the biotechnology sector firmly in the spotlight, investors are wondering how to access the lifesaving innovation on display.

However, biotech is a deep and complex sector, which requires extensive expertise to navigate. Scientific discoveries occur in all corners of the globe, but to gain exposure to the drugs providing solutions...

To continue reading this article...

Join Investment week

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

Trustpilot